Else Nutrition completes share consolidation and funding
Analysis based on 9 articles · First reported Jul 07, 2026 · Last updated Jul 07, 2026
The share consolidation and debt settlement are routine corporate actions with minimal direct market impact. The funding from Lind provides Else Nutrition with additional capital for its plant-based nutrition business, but the small scale limits broader market effects.
Else Nutrition Holdings Inc. announced the completion of a 1-for-10 share consolidation, reducing outstanding shares from 61.9 million to approximately 6.2 million. The company's shares will trade on the Canadian Securities Exchange under the symbol BABY on a post-consolidation basis starting July 8, 2026. Concurrently, Else settled $207,100 of debt by issuing 1,380,667 shares at $0.15 per share. Additionally, the company issued the fourth and final convertible security to Lind Global Fund III LP, receiving US$299,850 net proceeds, and issued 1,600,413 warrants exercisable at $0.2518 expiring in 2030. Lind also converted US$70,500 of outstanding convertible securities, resulting in the issuance of 628,704 shares.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard